or
Bookmark and Share
Itraconazole and saperconazole stereoisomers
   
Document Number
US Patent 6346518
Issued Date
February 12, 2002
Link
Inventors
Heeres; Jan (Vosselaar,BE)
Mesens; Jean Louis (Wechelderzande,BE)
Map
Abstract
The present invention is concerned with the stereoisomeric forms of itraconazole (X=Cl) and saperconazole (X=F), which may be represented by the formula ##STR1## and the pharmaceutically acceptable acid addition salt forms thereof, processes for preparing said stereoisomeric forms, the complexes thereof with cyclodextrin derivatives, pharmaceutical compositions comprising said complexes and methods of preparing said complexes and pharmaceutical compositions.
Drawing
Itraconazole and saperconazole stereoisomers - US Patent 6346518 Drawing
Drawing from US Patent 6346518
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
14
Comments:
no comments yet
Owner
Published
February 12, 2002
Application Number
08/295,885
Filed
January 26, 1995
US Classification
514/58   514/254.07 514/396 514/397 514/399 514/524 514/648 514/651 514/965 536/103 544/366 544/370 558/415 558/422
Int'l Classification
A61K   31/716   (20060101)   A61K   31/724   (20060101)   A61K   31/496   (20060101)  
Examiner
Attorney/Law Firm
Parent Case
CROSS-REFERENCE TO RELATED APPLICATIONS This application is based upon PCT Application Serial No. PCT/EP 93/00552, filed Mar. 10, 1993, which claims priority from U.S. patent application Ser. No. 07/853,648, filed on Mar. 18, 1992.
USPTO Field of Search
514/58   514/965   514/252   514/255   514/396   514/397   514/399   514/524   514/648   514/651   536/103   558/415   558/422   544/366   544/370  
Related Patents
6610670 - Cyclodextrin-drospirenone inclusion complexes - Owned by Schering Aktiengesellschaft (Berlin,DE)

Described are inclusion complexes formed between cyclodextrin and drospirenone. In a specific embodiment of the invention, the cyclodextrin is .beta.-cyclodextrin. The invention further relates to methods of providing such an inclusion complex, and to the use of said inclusion complex for improving the solubility of drospirenone, for providing pharmaceutical compositions, for use as a medicament in the treatment of symptoms associated with menopause and in female contraception.

7400383 - Environmental control in a reticle SMIF pod - Owned by Entegris, Inc. (Chaska, MN)

The present invention provides a standardized mechanical interface (SMIF) reticle pod that is configured to provide a controlled environment for supporting a reticle wherein the controlled environment is maintained substantially free of crystal growth causing contaminants. Accordingly, there is provided a layered filter with filter elements capable of filtering particulates and adsorbing gaseous contaminants. The filter has an inwardly facing face generally planar shaped with a surface area that is substantially half or more of the area of the reticle face. The inwardly facing face is placed in close proximity to the reticle patterned surface and has an area that is a significant fraction of the reticle patterned surface area. The SMIF pod is also provided with a purge system configured to inject a very dry gas within the controlled environment to flush the controlled environment of contaminants as well as to regenerate the filter.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us